|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Accounts receivable, net | |||||
| Inventory, net | |||||
| Loans receivable, short-term | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Total current assets | |||||
| Property and equipment, net | |||||
| Right-of-use assets | |||||
| Intangible assets, net | |||||
| Loans receivable, long-term | |||||
| Investments | |||||
| Goodwill | |||||
| Deferred tax asset | |||||
| Other non-current assets | |||||
| Total non-current assets | |||||
| TOTAL ASSETS | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Short-term borrowings | |||||
| Income taxes payable | |||||
| Current portion of lease liabilities | |||||
| Deferred consideration, and other payables, short-term | |||||
| Total current liabilities | |||||
| Long-term notes and loans payable, net | |||||
| Lease liabilities | |||||
| Deferred tax liability | |||||
| Deferred consideration, long-term | |||||
| Other long-term liabilities | |||||
| Total non-current liabilities | |||||
| TOTAL LIABILITIES | |||||
| Share capital | |||||
| Additional paid-in-capital | |||||
| Accumulated other comprehensive loss | |||||
| Accumulated deficit | |||||
| Equity of Cresco Labs Inc. | |||||
| Non-controlling interests | |||||
| TOTAL SHAREHOLDERS’ EQUITY | |||||
| ASSETS | |||||
| Current assets: | |||||
| Cash and Cash Equivalent | |||||
| Restricted cash | |||||
| Accounts receivable, net | |||||
| Inventory, net | |||||
| Lease Liability | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Total current assets | |||||
| Non-current assets: | |||||
| Property and equipment, net1 | |||||
| Right-of-use assets | |||||
| Right-or-use assets - operating, net | |||||
| Right-of-use assets - finance, net | |||||
| Total right-of-use assets | |||||
| Intangible assets, net1 | |||||
| Goodwill | |||||
| Deferred tax asset | |||||
| Other non-current assets | |||||
| Total non-current assets | |||||
| TOTAL ASSETS | |||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||
| Current liabilities: | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Short-term borrowings | |||||
| Income taxes payable | |||||
| Current portion of lease liabilities | |||||
| Less: current lease liabilities | |||||
| Deferred and contingent consideration, short-term | |||||
| Total current liabilities | |||||
| Non-current liabilities: | |||||
| Long-term notes and loans payable, net | |||||
| Lease liabilities | |||||
| Operating lease liabilities | |||||
| Finance lease liabilities | |||||
| Total lease liabilities | |||||
| Deferred tax liability | |||||
| Deferred and contingent consideration, long-term | |||||
| Tax receivable agreement liability | |||||
| Uncertain tax position liability | |||||
| Other long-term liabilities | |||||
| Total non-current liabilities | |||||
| TOTAL LIABILITIES | |||||
| SHAREHOLDERS’ EQUITY | |||||
| Share capital | |||||
| Additional paid-in-capital | |||||
| Accumulated other comprehensive loss | |||||
| Accumulated deficit | |||||
| Equity of Cresco Labs Inc. | |||||
| Non-controlling interests | |||||
| TOTAL SHAREHOLDERS’ EQUITY | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||
Loading...